> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Use of Expedited Drug Review Programs Increasing
- URL: https://www.fdaweb.com/use-of-expedited-drug-review-programs-increasing/
- Published: 2022-11-01T12:00:00.000Z
- Updated: 2026-09-14T18:04:48.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153099

FDA researchers say the use of expedited drug development and review programs increased from 2008 to 2021 and is likely to continue increasing. Writing in a *JAMA Network* open-access [article](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2798005?ref=fdaweb.com), the researchers say they wanted to learn how often the accelerated approval, breakthrough therapy, fast track, and priority review programs are used alone and in combination.

“The findings suggest that expedited programs have an increasing role in bringing novel drugs to market in the U.S., especially orphan and biologic products,” they write.